Sigma receptor ligands and the use thereof
US6087346A · kind A · utility
54Cited by
14References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 21, 1996 |
| Grant date | Jul 11, 2000 |
| Priority date | — |
| Expiry date | Feb 21, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to methods for the treatment of central nervous system disorders, neurological disorders, gastrointestinal disorders, drug abuse, angina, migraine, hypertension and depression by administering a pharmaceutical composition comprising an effective amount of certain sigma receptor ligands to a patient in need of such treatment. The invention further relates to novel sigma receptor ligands having high binding to the sigma receptor and pharmaceutical compositions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.